Showing 901 - 920 results of 1,123 for search '"prostate"', query time: 0.05s Refine Results
  1. 901

    Cyclooxygenase-2 Mediated Regulation of E-Cadherin Occurs in Conventional But Not Early-Onset Gastric Cancer Cell Lines by R. Sitarz, R. J. Leguit, W. W. J. de Leng, F. H. M. Morsink, W. P. Polkowski, R. Maciejewski, G. J. A. Offerhaus, A. N. Milne

    Published 2009-01-01
    “…A relationship between them is documented in non-small cell lung and prostate cancer. We present novel evidence of a relationship between COX-2 and E-cadherin expression in gastric cancer.…”
    Get full text
    Article
  2. 902

    Metastatic Gastrointestinal Adenocarcinoma with Osteoblastic Activity: A Case Report of Esophageal and Colonic Primaries by Brett Matthew Lowenthal, Ahmed S. Shabaik, Mark A. Valasek

    Published 2016-01-01
    “…Adenocarcinoma with osteoblastic metastases is classically seen in prostate, breast, and lung primaries. Less common primary sites include thyroid, kidney, and stomach. …”
    Get full text
    Article
  3. 903

    The effects of Lepidium meyenii on MSG-induced subfertility in male Wistar rats: Targeting oxidative stress, pro-inflammatory cytokines, steroidogenic enzymes, and reproductive hor... by Temidayo S. Omolaoye, Surendra Singh Rawat, Naglaa Gamil Shehab, Eslam El Nebrisi, Stefan S. Du Plessis

    Published 2025-02-01
    “…Spermatozoa were collected from the caudal epididymis for sperm assessments. The testis and prostate were used for biochemical assays and immunofluorescent localization of biomarkers of interest. …”
    Get full text
    Article
  4. 904

    Comparison of TAP block and epidural analgesia for postoperative analgesia after robotic-assisted radical prostatectomy by O.O. Volkov, Lutsenko V.V., M.O. Plis, M.V. Pavlenko, Krishtafor D.A.

    Published 2023-06-01
    “…When analyzing the statistical data it was found that the volume of the prostate did not differ in the study groups, as well as the duration of the operation and the amount of blood loss (р>0.05). …”
    Get full text
    Article
  5. 905

    Physical Examination & Health Assessment / by Jarvis, Carolyn

    Published 2016
    Table of Contents: “…Evidence-based assessment -- Cultural competence -- The interview -- The complete health history -- Mental status assessment -- Substance use assessment -- Domestic and family violence assessments -- Assessment techniques and safety in the clinical setting -- General survey, measurement, vital signs -- Pain assessment: the fifth vital sign -- Nutritional assessment -- Skin, hair, and nails -- Head, face, and neck, including regional lymphatics -- Eyes -- Ears -- Nose, mouth, and throat -- Breasts and regional lymphatics -- Thorax and lungs -- Heart and neck vessels -- Peripheral vascular system and lymphatic system -- Abdomen -- Musculoskeletal system -- Neurologic system -- Male genitourinary system -- Anus, rectum, and prostate -- Female genitourinary system -- The complete health assessment: adult -- The complete physical assessment: infant, child, and adolescent -- Bedside assessment and electronic health recording -- The pregnant woman -- Functional assessment of the older adult.…”
    View in OPAC
    Book
  6. 906

    Serous Cystadenoma of the Pancreas Presenting as a Third Primary Neoplasm by Aydın Şeref Köksal, Aysel Ülker, Mehmet Asıl, Bilge Tunç, Arda Kemal, Metin Şavkılıoğlu, Yusuf Özoğul, Nesrin Turhan

    Published 2003-01-01
    “…A 10 cm mass involving the body of the pancreas was observed in the computed tomography of a 61-year-old man with a previous history of bladder and prostate carcinoma. Ultrasonography and computed tomography of the mass demonstrated multiple small cysts associated with a central calcified scar. …”
    Get full text
    Article
  7. 907

    Interpreting Cancer Incidence Rates and Trends: A Review of Control Factors and Worldwide Statistics by Hassan Bahrami

    Published 2024-01-01
    “…Data Sources: This article reviews the literature to address the most important control factors associated with cancer prevention and control for some of the most common types of cancer in the lung, breast, colon, stomach, prostate, cervix, and skin. Study Selection: To have a reliable interpretation, the latest statistics on age-standardized cancer incidence rates published by the International Agency for Research on Cancer are analyzed according to specific root causes. …”
    Get full text
    Article
  8. 908

    Role of gp91phox Homolog Nox1 in Induction of Premalignant Spindle Phenotypes of HPV 16 E6/E7—Immortalized Human Keratinocytes by Walee Chamulitrat

    Published 2010-01-01
    “…While Nox1 has been shown to be expressed in human colon and prostate cancers, however, limited studies have demonstrated the involvement of Nox1 in an early step of cell transformation. …”
    Get full text
    Article
  9. 909

    Second Suburethral Sling Implantation for the Recurrent Urinary Incontinence after Radical Prostatectomy when First Sling Surgery was Non-Effective: Case Report by Aušra Černiauskienė, Ieva Rimaitė

    Published 2023-11-01
    “…We present a case report of a 62-year-old man who underwent radical prostatectomy due to prostate cancer in 2018 and experienced moderate degree urinary incontinence. …”
    Get full text
    Article
  10. 910

    Biochemical Bone Turnover Markers and Osteoporosis in Older Men: Where Are We? by Pawel Szulc

    Published 2011-01-01
    “…In men receiving antiresorptive therapy for prostate cancer, zoledronate, denosumab and toremifene decrease significantly levels of bone resorption and bone formation markers. …”
    Get full text
    Article
  11. 911

    Primary retroperitoneal schwannoma. Case presentation by Annia Rivacoba Betancourt, Yusnier Varona Varona, Javier Cruz Batista

    Published 2023-10-01
    “…The physical examination confirmed, through digital rectal examination, a tonic sphincter, an empty rectal ampulla, a grade IV enlarged prostate with a fibromuscular consistency with a smooth and mobile surface; not painful. …”
    Get full text
    Article
  12. 912

    Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report by Cynthia A. Jackevicius, Mannhu N. Ton

    Published 2009-01-01
    “…A 59-year-old man treated with warfarin for aortic valve replacement was prescribed high-dose ketoconazole and hydrocortisone for the treatment of prostate cancer. Despite lowering the warfarin dosage by 35% during the start of high dose ketoconazole, an additional dose reduction was required subsequently when the INR rose from 2.62 to 3.82 within nine days. …”
    Get full text
    Article
  13. 913

    Sarcomatoid Renal Cell Carcinoma Metastasis to the Penis by Victor D. Liou, Oussama M. Darwish, Mary M. Henry, Ik C. Jun, Sameer A. Siddiqui

    Published 2015-01-01
    “…These cancers are most frequently a result of an aggressive or poorly managed primary prostate or bladder cancer and rarely a metastasis from a primary kidney tumor. …”
    Get full text
    Article
  14. 914

    Ochronotic arthropathy: skeletal manifestations and orthopaedic treatment by Khaled Hamed Salem, Alyaa Diaa Elmoghazy

    Published 2025-02-01
    “…Several clinical manifestations were described including coronary and valvular calcification, aortic stenosis, limited chest expansion, and renal, urethral and prostate calculi as well as ocular and cutaneous pigmentation. …”
    Get full text
    Article
  15. 915

    A Rare Cause of Testicular Metastasis: Upper Tract Urothelial Carcinoma by Alper Nesip Manav, Ercan Kazan, Mehmet Şirin Ertek, Akın Soner Amasyalı, Nil Çulhacı, Haluk Erol

    Published 2014-01-01
    “…Primary tumor sources are prostate, lung, and gastrointestinal tract for metastatic testicular cancers. …”
    Get full text
    Article
  16. 916

    Sample Size Calculation for Controlling False Discovery Proportion by Shulian Shang, Qianhe Zhou, Mengling Liu, Yongzhao Shao

    Published 2012-01-01
    “…We illustrate the method using estimated correlations from a prostate cancer dataset.…”
    Get full text
    Article
  17. 917

    An Interventional Magnetic Resonance Imaging Technique for the Molecular Characterization of Intraprostatic Dynamic Contrast Enhancement by Cynthia Ménard, Robert C. Susil, Peter Choyke, Jonathan Coleman, Robert Grubb, Ahmed Gharib, Axel Krieger, Peter Guion, David Thomasson, Karen Ullman, Sandeep Gupta, Virginia Espina, Lance Liotta, Emanuel Petricoin, Gabor Fitchtinger, Louis L. Whitcomb, Ergin Atalar, C. Norman Coleman, Kevin Camphausen

    Published 2005-01-01
    “…Here we demonstrate the feasibility of precisely colocalizing DCE-MRI data with the genomic and proteomic profiles of underlying biopsy tissue using a novel MRI-guided biopsy technique in patients with prostate cancer.…”
    Get full text
    Article
  18. 918

    Plasmacytoid Urothelial Carcinoma of the Urinary Bladder Metastatic to the Duodenum: A Case Report—Diagnostic Relevance of GATA3 Immunohistochemistry by Hermann Brustmann

    Published 2017-01-01
    “…A transurethral bladder and a prostate resection specimen displayed infiltration of neoplastic cells in a spray-like discohesive pattern with occasional formation of small irregular nests and cord-like arrangements. …”
    Get full text
    Article
  19. 919

    Molecular glue degrader for tumor treatment by Yuhan Hu, Yan Yan, Jiehao Wang, Jiangxue Hou, Quande Lin

    Published 2024-12-01
    “…Targeted Protein Degradation (TPD) represented by Proteolysis-Targeting Chimeras (PROTAC) is the frontier field in the research and development of antitumor therapy, in which oral drug HP518 Receives FDA Proceed Authorization for its IND Application for Prostate Cancer Treatment. Recently, molecular glue, functioning via degradation of the target protein is emerging as a promising modality for the development of therapeutic agents, while exhibits greater advantages over PROTAC, including improved efficiency, resistance-free properties, and the capacity to selectively target “undruggable” proteins. …”
    Get full text
    Article
  20. 920

    The role of tribbles homolog 2 in cell proliferation by Wenkang Zhang, Mingkang Li, Minhao Zhang, Gaoliang Yan, Chengchun Tang

    Published 2025-01-01
    “…TRIB2 is not only involved in the physiological proliferation of cells (granulosa cells, myoblasts, naive T cells, and thymocytes) during normal development but also in the pathological proliferation of vascular smooth muscle cells and a variety of cancer cells (lung cancer cells, liver cancer cells, leukemia cells, pancreatic cancer cells, gastric cancer cells, prostate cancer cells, thyroid cancer cells, cervical cancer cells, melanoma cells, colorectal cancer cells, ovarian cancer cells and osteosarcoma cells) under disease conditions. …”
    Get full text
    Article